Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors
Amy J. Eshleman, Shanthi Nagarajan, Katherine M. Wolfrum, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114293-114293
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Youwen Zhuang, Yue Wang, Bingqing He, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4361-4375.e19
Open Access | Times Cited: 149
The anomalous pharmacology of fentanyl
Eamonn Kelly, Katy J. Sutcliffe, Damiana Cavallo, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 797-812
Closed Access | Times Cited: 91
Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 84
Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice
Grant C. Glatfelter, Eline Pottie, John S. Partilla, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 11, pp. 1181-1196
Open Access | Times Cited: 54
Fentanyl and its derivatives: Pain-killers or man-killers?
Jiří Patočka, Wenda Wu, Patrik Olekšák, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e28795-e28795
Open Access | Times Cited: 12
Pharmacologic Characterization of Substituted Nitazenes atμ,κ, andΔOpioid Receptors Suggests High Potential for Toxicity
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 10
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
Neil B. Varshneya, Sherif H. Hassanien, Melissa C. Holt, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114805-114805
Open Access | Times Cited: 42
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2AReceptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter
Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 1, pp. 62-75
Open Access | Times Cited: 21
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 20
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Meng-Hua M. Tsai, Li Chen, Michael H. Baumann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 854-867
Closed Access | Times Cited: 5
A Drd1-cre mouse line with nucleus accumbens gene dysregulation exhibits blunted fentanyl seeking
Annalisa Montemarano, Logan D. Fox, Farrah A Alkhaleel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl
Sabrine Bilel, Joaquim Azevedo Neto, Raffaella Arfè, et al.
Neuropharmacology (2022) Vol. 209, pp. 109020-109020
Open Access | Times Cited: 22
Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression
Neil B. Varshneya, Sherif H. Hassanien, Melissa C. Holt, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 226, pp. 173572-173572
Open Access | Times Cited: 15
Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl
Bing Xie, Valerie P. Le Rouzic, Alexander Goldberg, et al.
Neuropharmacology (2023) Vol. 227, pp. 109442-109442
Open Access | Times Cited: 14
Carfentanil is a β‐arrestin‐biased agonist at the μ opioid receptor
Nokomis Ramos‐Gonzalez, Sam Groom, Katy J. Sutcliffe, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 18, pp. 2341-2360
Open Access | Times Cited: 14
Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors
Neil B. Varshneya, D. Matthew Walentiny, L Moisă, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 208, pp. 173242-173242
Open Access | Times Cited: 26
Tackling new psychoactive substances through metabolomics: UHPLC-HRMS study on natural and synthetic opioids in male and female murine models
Gaia Di Francesco, Camilla Montesano, Flaminia Vincenti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress
Marthe M. Vandeputte, Lakshmi Vasudevan, Christophe P. Stove
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108161-108161
Open Access | Times Cited: 14
State and Future Science of Opioids and Potential of Biased-ligand Technology in the Management of Acute Pain After Burn Injury
David M Hill, Erik DeBoer
Journal of Burn Care & Research (2023) Vol. 44, Iss. 3, pp. 524-534
Open Access | Times Cited: 8
A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor
Bing Xie, Alexander Goldberg, Lei Shi
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2309-2321
Open Access | Times Cited: 13
Antinociceptive and Discriminative Stimulus Effects of Six Novel Psychoactive Opioid Substances in Male Rats
Ellen A. Walker, Christina Chambers, Matthew Gerard Korber, et al.
Journal of Pharmacology and Experimental Therapeutics (2021) Vol. 379, Iss. 1, pp. 1-11
Open Access | Times Cited: 13
Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics
Piotr F. J. Lipiński, Joanna Matalińska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2766-2766
Open Access | Times Cited: 9
Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor
Marie H. Deventer, Mattias Persson, Antonio Laus, et al.
Archives of Toxicology (2023) Vol. 97, Iss. 5, pp. 1367-1384
Closed Access | Times Cited: 5
Structurally diverse fentanyl analogs yield differential locomotor activities in mice
Neil B. Varshneya, D. Matthew Walentiny, David L. Stevens, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173496-173496
Open Access | Times Cited: 8
Reinforcing effects of fentanyl analogs found in illicit drug markets
Alexander D. Maitland, Shelby A. McGriff, Grant C. Glatfelter, et al.
Psychopharmacology (2024) Vol. 241, Iss. 11, pp. 2375-2383
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top